Trajan Accelerator featured as an initiative for the 2020 economy and beyond

Trajan Accelerator featured as an initiative for the 2020 economy and beyond

June 16, 2016

From the Business/Higher Education Round Table (Australia):

The Seeds of Transition: Initiatives for the 2020 Economy and Beyond

A repositioned economy based on structural change enabling knowledge/IP translation and not restricted by geography is an outcome that will serve Australia well as we move further into the 21st century. And so it is that the contributors for this edition of the B/HERT News bring a focus to initiatives that will be a part of this journey.

Read the article Trajan Accelerator; An Initiative to Build Sustainable Businesses Driven by Passionate People with Great Ideas on pages 9 - 11 of B/HERT News #35.

Download
B/HERT News #35 [PDF]

More information
Trajan Accelerator
Business/Higher Education Round Table (B/HERT) 




Also in News

Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst
Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst

September 07, 2020

Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.

Read More

European patent for Trajan’s hemaPEN
European patent for Trajan’s hemaPEN

July 13, 2020

Trajan Scientific and Medical is proud to advise that the European Patent Office will be granting a patent for hemaPEN® as a liquid collection device in Belgium, France, Germany, Ireland, Luxembourg, Monaco, Switzerland, Liechtenstein and the United Kingdom. Extensions are being sought across the remainder of Europe.

Read More

US FDA listing of Trajan’s hemaPEN blood microsampling device
US FDA listing of Trajan’s hemaPEN blood microsampling device

July 02, 2020

Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.

Read More